First gene-editing treatment injected into the blood reduces toxic protein for up to 1 year
Breakthrough gene-editing technology belongs to Harvard, MIT -U.S. tribunal
New technology can assist bioprosthetic heart valve patients by avoiding additional replacement surgery
Yale School of Medicine
Gene editing gets safer thanks to redesigned Cas9 protein